With all the excitement around AI accelerating science in the next few years, it can be easy to lose sight of the impact models are having _today_ on some of the hardest challenges in the world's leading pharmaceutical companies. Chai-3 was a step-change for us and our partners.
Frontier drug discovery programs require frontier capabilities. Today, we’re excited to share that BMS will be using Chai’s models to support the discovery of new therapeutics. Since rolling out Chai-3 to partners at the start of this year, we’ve partnered with @EliLillyandCo,
